Guoqiao Wang

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Remote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention Studies

  2025-10-03

• Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

  Alzheimer s & Dementia · 2025-10-01

• The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

  Alzheimer s & Dementia · 2025-09-01 · 3 citations

• Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN‐TU‐001 trial

  Alzheimer s & Dementia · 2025-07-01 · 3 citations

• Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

  Acta Neuropathologica · 2025-06-03 · 4 citations

• Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia

  Nature Medicine · 2025-02-10 · 22 citations

• The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset

  Brain · 2025-02-04 · 16 citations

• Delaying symptom onset in Dominantly Inherited Alzheimer’s Disease: Long‐term gantenerumab treatment results from the DIAN‐TU trial

  Alzheimer s & Dementia · 2024-12-01

• Safety of higher doses of gantenerumab in the open‐label extension of the DIAN–TU‐001 trial

  Alzheimer s & Dementia · 2024-12-01

• MRI and PET findings with long‐term gantenerumab treatment: results from the DIAN‐TU trial

  Alzheimer s & Dementia · 2024-12-01

• Insights into high‐risk or unusual ARIA: manifestations and individualized approaches to management through cases from DIAN‐TU gantenerumab open‐label study

  Alzheimer s & Dementia · 2024-12-01

• Impact of gantenerumab amyloid removal therapy on established Alzheimer Disease fluid biomarkers

  Alzheimer s & Dementia · 2024-12-01

• Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data

  Statistics in Medicine · 2024-11-25 · 7 citations

• Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialPreprint

  medRxiv · 2024-11-06 · 6 citations

• The CentiMarker Project: Standardizing Quantitative Alzheimer’s disease Fluid Biomarkers for Biologic InterpretationPreprint

  medRxiv · 2024-07-27 · 2 citations